Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Váldodahkkit: Rory Barry (Dahkki), Gregg Murray (Dahkki), Sally McGrath (Dahkki), Clive Kilgallen (Dahkki), Karen Eustace (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2024-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...